Skip to main content
. 2018 Nov 20;9:1312. doi: 10.3389/fphar.2018.01312

Figure 5.

Figure 5

Effect of ABCC10 on cell viability of gefitinib-sensitive and -resistant NSCLC cells after gefitinib exposure. (A,B) Influence of ABCC10 overexpression on cell viability of gefitinib-sensitive PC9 and H292 cells treated with various concentration of gefitinib for 72 h. (C,D) Influence of ABCC10 knockdown on cell viability of gefitinib-resistant PC9/GR and H292/GR cells treated with various concentration of gefitinib for 72 h. *P < 0.05, **P < 0.01 compared to the empty-vector-transfected cells (EV) or shMock-transfected cells (shMock).